A new study reveals that a common malaria and arthritis drug, hydroxychloroquine, is an effective tool in combating Covid-19. The study was undertaken by the Henry Ford Health System between March and May involving 2,541 patients. WND reports: While 26.4% of those who did not receive hydroxychloroquine died, only 13% of those who did get the drug died. The study was headlined, “Treatment with hydroxychloroquine cut death rate significantly in COVID-19 patients, Henry Ford Health System study shows.” The study published in the International Journal of Infectious Diseases said, “all patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American.” The hospital attributed its high success rate to giving people the drug within 48 hours of admittance to their hospitals. Speaking on behalf of the hospital, Dr. Marcus Zervos said: “The findings have been highly analyzed and peer-reviewed.” “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, …